Reports

7498 Results (Page 170 of 300)

Pharmaceuticals Markets Research Reports

Pharmaceuticals

China Atopic Dermatitis Drugs Market Analysis

China Atopic Dermatitis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for atopic dermatitis drugs is driven by the increasing prevalence of the condition, especially among children, leading to a demand for effective treatments. Some of the prominent players in the market include Pfizer Inc., Sanofi SA, Novartis AG, Regeneron Pharmaceuticals Inc., Galderma S.A., Leo Pharma A/S, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, and Johnson & Johnson.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Infectious Wound Care Management Market Analysis

Egypt infectious wound care management market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is expanding as a result of the ageing population, the prevalence of chronic diseases, and technologically advanced and lifestyle-related wound care products. The key players in this market are Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Ethicon (Johnson & Johnson), Baxter International, URGO Medical, Coloplast Corp, Medtronic, 3M, Derma Sciences Inc. (Integra LifeSciences), Medline Industries, Advancis Medical, B. Braun Melsungen AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

France Phycocyanin Market Analysis

France Phycocyanin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Phycocyanin market is growing globally due to the growth and expansion of the food and beverage industry, the food and beverage sector's increasing focus on innovations, consumers' growing awareness of the benefits of consuming foods and beverages high in protein and other nutrients, the accelerating rate of the use of food additives and colorants, and rising personal disposable income.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Cannabis Market Analysis

Indonesia Cannabis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the cannabis industry include the increasing trend of legalization, both for medical and recreational purposes, which expands the market and drives demand. The growing acceptance of cannabis for medical applications, as it provides relief for various conditions, contributes to market growth. In the global cannabis market, several prominent players have established their presence. Companies such as Canopy Growth Corporation, Curaleaf Holdings, Inc., Green Thumb Industries Inc. (GTI), etc., have gained significant market share.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Kidney Cancer Drugs Market Analysis

Japan kidney cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising consumer awareness, technical improvements, and the appeal of kidney and renal cancer drugs goods are all contributing reasons to the market's expansion. Some of the major key players in this market are Pfizer Inc (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Rabies Vaccine Market Analysis

Kenya Rabies Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rabies Vaccine market is growing globally due to the rising incidence of rabies, government initiatives and vaccination programs, growing pet ownership and animal healthcare realizing the importance of vaccination, technological advancements leading to more safe and effective vaccines, collaborations and partnerships between vaccine manufacturers and government bodies. Serum Institute of India Pvt. Ltd, Novartis AG, Cadila Pharmaceuticals, and Merck & Co., Inc., Sanofi, ADS Diagnostic Ltd, GSK plc, Berna Biotech Pharma GmbH, and AstraZeneca are the key global market players in rabies vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Cough Remedies Market Analysis

Mexico Cough Remedies Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The incidence of respiratory disorders, changing consumer preferences, innovations in product formulations, and marketing and promotional techniques adopted by key industry players are important drivers of cough remedies market. The global cough remedies market is dominated by several key players such as Johnson & Johnson and Procter & Gamble, GlaxoSmithKline and Reckitt Benckiser Group, Novartis International, Pfizer, Sanofi, Boehringer Ingelheim, Bayer, and AstraZeneca.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Meningococcal Vaccines Market Analysis

Philippines meningococcal vaccines market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of meningococcal disease among young children and adolescents globally is one of the key factors driving the market's rise. Additionally, market expansion is being fueled by the acceptance of routine vaccinations and an overall rise in health consciousness. The major key players in this market are GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Subcutaneous Immunoglobulin Market Analysis

Saudi Arabia Subcutaneous Immunoglobulin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Subcutaneous Immunoglobulin market is growing globally due to the Increasing prevalence of chronic and autoimmune diseases, the trend towards providing healthcare in the patient's home, improvements in infusion technology, and the advantages and benefits of subcutaneous delivery, rise in the prevalence of sedentary lifestyle due to urbanization and stress. Baxter, Biotest AG., China Biologic Products Holdings, Inc., CSL Limited, Grifols, S.A., Kedrion S.p.A, Octapharma, GREEN CROSS CORP, Coram LLC, Momenta Pharmaceuticals, Option Care Enterprises, Inc., ADMA Biologics, Inc., Gentian Diagnostics AS, Mabtech, J. Mitra & Co. Pvt. Ltd, Cygnus Technologies, Kamada Pharmaceuticals are the key global market players in subcutaneous immunoglobulin market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Enzymatic Wound Debridement Market Analysis

South Africa Enzymatic Wound Debridement Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growing prevalence of chronic wounds and diabetic ulcers, Advancements in enzymatic debridement technology, increasing demand for non-invasive and painless wound debridement methods and rising geriatric population prone to chronic wounds are drivers in Enzymatic Wound Debridement Market. Global Companies in the Enzymatic Wound Debridement Market are Smith & Nephew plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Paul Hartmann AG, Hollister Incorporated, Integra LifeSciences Corporation, Organogenesis Inc. and Misonix Inc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Opioid Drugs Market Analysis

Spain opioid drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The opioid industry is anticipated to rise as a result of expanding painkiller care facilities, altered prescription laws, and intense generic manufacturers' attention on Abuse-Deterrent Formulation (ADF). The major players in this market are Eva Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, and Purdue Pharmaceuticals L.P.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UAE Type 1 Diabetes Mellitus Drugs Market Analysis

UAE Type 1 Diabetes Mellitus Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Type 1 Diabetes Mellitus Drugs market is growing globally due to the rising prevalence of type 1 diabetes mellitus, advancements in insulin therapies, technological advancements in insulin delivery systems, increasing focus on personalized medicine, rising healthcare expenditure, favorable reimbursement policies, increasing patient awareness and education, research and development initiatives and collaborations between pharmaceutical companies and academic institutions. Novo Nordisk, Eli Lilly and Company, Sanofi, Medtronic, Abbott Laboratories, Dexcom, Zealand Pharma, Xeris Pharmaceuticals, Insulet Corporation, and Tandem Diabetes Care are the key global market players in type 1 diabetes mellitus drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Gynecology Drugs Market Analysis

US Gynecology Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gynecology drugs market include the increasing prevalence of gynecological disorders, growing awareness and focus on women's health, technological advancements, and supportive government initiatives promoting women's healthcare. Key Global Players in Gynecology Drugs Market are Bayer AG, Pfizer Inc., Merck & Co., Novartis AG, Johnson & Johnson, AbbVie Inc., Allergan plc, Eli Lilly and Company, AstraZeneca plc and GlaxoSmithKline plc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Paracetamol Market Analysis

Vietnam paracetamol market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising geriatric populations, expanding emerging markets, expanding R&D efforts in the healthcare industry, and rising technological developments and modernization in the paracetamol production process will all further open up new potential for the paracetamol market. Some of the key players in this market are Bristol Laboratories, GlaxoSmithKline, Mallinckrodt, Venipharm, Novacyl, FarmalíderGroup, bene-Arzneimittel GmbH, Wockhardt UK Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Pharmaceutical Analytical Testing Outsourcing Market Analysis

Brazil Pharmaceutical Analytical Testing Outsourcing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical analytical testing outsourcing is growing rapidly as a result of increase in the usage of pharmaceuticals and therapeutics requiring specialized manufacturing capabilities, rise in the presence of strict regulations and requirement of pertaining to the standards provided by the authorities, growth in modernization and innovations requiring reduction of operating costs of manufacturing and development, rise in the demand for biosimilars and biopharmaceutical products as well as for analytical drugs, increase in number of products in the pipeline and rise in the improved efficiency in testing, reduced cost, quicker & reliable results and rising research and development activities in the healthcare sector. Exova, Charles River Laboratories, Boston Analytical, West Pharmaceutical Services, Inc., Dalton Pharma Services, Merck KGaA, Cambrex Corporation, WuXi AppTec, Source BioScience, Ajinomoto Bio-Pharma, Catalent, Inc., Gateway Analytical, Alcami Corporation, Aztech Sciences Inc., Recro, and AptarGroup, Inc. are few companies in Pharmaceutical Analytical Testing Outsourcing.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Autologous Matrix-induced Chondrogenesis Market Analysis

China Autologous Matrix-induced Chondrogenesis Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The AMIC market is driven by increasing knee injuries and cartilage defects, advancements in regenerative medicine, and the growing geriatric population. However, limited awareness and high costs are restraints. Ongoing research, collaborations, and investments are expected to address restraints and drive further advancements in the AMIC market. Key players globally in AMIC market are Geistlich Pharma AG, Arthrex, Zimmer Biomet Holdings, Smith & Nephew plc, Vericel Corporation, and B. Braun Melsungen AG, among others.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Inflammatory Bowel Disease (IBD) Drugs Market Analysis

Egypt Inflammatory Bowel Disease (IBD) drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Numerous variables, including genetic predisposition, environmental triggers, and immune system disturbance, are to blame for the rising prevalence of ulcerative colitis and Crohn's disease. Most people who have ulcerative colitis or Crohn's disease have a family history of the condition. This will act as a driver for Inflammatory Bowel Disease (IBD) drugs market. AbbVie Inc. (U.S.) Takeda Pharmaceutical Company Limited (Tokyo) UCB S.A. (Belgium) Bausch Health Companies Inc. (Canada) Bristol-Myers Squibb Company (U.S.) Pfizer Inc. (U.S.) Celltrion Inc. (South Korea) Johnson & Johnson Services, Inc. (U.S.) are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

France Pigments Market Analysis

France Pigments Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pigments market is growing globally due to the increasing demand from end use industries like paints and coatings, automotive, plastics, construction, textiles, growing construction and infrastructure development, technological advancements in pigments manufacturing like nanotechnology and availability of products on e-commerce platforms. The Chemours Company, Huntsman Corporation, Tronox Holdings plc, Sun Chemical Corporation, Clariant Corporation, LANXESS Corporation, Kronos Worldwide, Inc., PPG Industries, Inc., Ferro CorporationAmerican Colors, Inc. are the key global market players in pigments market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Carboprost Tromethamine Market Analysis

Indonesia Carboprost Tromethamine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of postpartum haemorrhage, increased focus on maternal healthcare, developments in healthcare infrastructure, technological innovations in drug delivery, increasing maternal age, and supportive government initiatives are driving the carboprost tromethamine market. Pfizer Inc., Ferring Pharmaceuticals, JHP Pharmaceuticals, Hikma Pharmaceuticals, and Hemofarm A.D. are some of the leading global key competitors in the carboprost tromethamine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Knee Cartilage Repair Market Analysis

Japan knee cartilage repair market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases. The major key players in this market are B. Braun Melsungen AG, Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Remicade Biosimilar Market Analysis

Kenya Remicade Biosimilar Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Remicade Biosimilar market is growing globally due to the rising prevalence of autoimmune illnesses including rheumatoid arthritis, plaque psoriasis, introduction of a biosimilar version could provide financial relief for healthcare systems and increased access to essential medication for patients, quicker intravenous administration reaction times, patent expiry of branded versions will create opportunity biosimilars over other branded counterparts, thus increasing remicade biosimilar demand, growing awareness about its long-term benefits and better reimbursement scenario, technological advancements in the field of biosimilars, an increase in R&D spending by pharmaceutical companies and growing awareness about biosimilars among healthcare professionals and patients. Janssen Biotech Inc., Merck &Co., Pfizer Inc. (AC. Hospira), Celltrion Inc., Alvogen, Napp Pharmaceuticals, and Nippon Kayaku are some major players in the global Remicade (infliximab mAb) market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Demineralized Bone Matrix Market Analysis

Mexico Demineralized Bone Matrix Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of bone-related disorders, growing geriatric population, advancements in regenerative medicine, favourable reimbursement policies, and an increase in dental implant procedures are driving the demineralized bone matrix (DBM) market, stimulating demand for DBM products in orthopaedic and dental applications. Medtronic plc, Zimmer Biomet Holdings, Johnson & Johnson, Stryker Corporation, NuVasive, RTI Surgical Holdings, Orthofix Medical Inc., SeaSpine Holdings Corporation, AlloSource and Xtant Medical Holdings are amongst the global key players in Demineralized Bone Matrix Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Metabolic Disorder Drugs Market Analysis

Philippines metabolic disorder drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The ageing population, rising diabetes and obesity rates, and the prevalence of metabolic disorders are all driving factors for the global market for medications treating these conditions. Another element fueling the expansion of this market is an increase in public awareness of various ailments and associated pharmacological treatments. Some of the major key players in this market are AbbVie, Actelion Pharmaceuticals, Amgen, Astra Zeneca, Biocon, BioMarin Pharmaceutical, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Supportive Care Agents in Cancer Market Analysis

Saudi Arabia Supportive Care Agents in Cancer Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Supportive Care Agents in Cancer market is growing globally due to the increasing cancer incidence which causes growth in need for effective supportive care measures to manage treatment-related symptoms and improve patients' quality of life, side effects caused by cancer treatments which require supportive care, growing emphasis on patient-centered care, increased awareness and education among patients and healthcare professionals, support by regulatory bodies and launch of new products. Acacia Pharma Group Plc, Teva Pharmaceuticals Industries Ltd, Fagron Group, KYOWA HAKKO BIO CO., LTD., APR, and F. Hoffmann-La Roche Ltd are the key global market players in supportive care agents in cancer market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Enzyme Inhibitors Market Analysis

South Africa Enzyme Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing prevalence of enzyme-related disorders, advances in drug discovery and development, a greater emphasis on personalized therapy, and increased research spending and collaborations are driving the enzyme inhibitors market. Novartis International AG, Roche Holding AG, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi S.A., Boehringer Ingelheim International GmbH, Bayer AG, Takeda Pharmaceutical Company Limited, AbbVie Inc., and Merck KGaA are the global participants in the enzyme inhibitors market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up